This medicinal product is subject to additional monitoring. Eklira genuair aclidinium bromide is the second inhaled longacting anticholinergic to be licensed for the maintenance treatment of copd. Please select your inhaler by clicking on the images below. Peak inspiratory flow through the genuair inhaler in. There are many different types of inhaler, which can be confusing. Aclidinium bromide eklira genuair is recommended as an option for use within nhs. Pdf clinical potential of aclidinium bromide in chronic. Aclidiniumformoterol brimica genuair, duaklir genuair. You can help by reporting any side effects you may get. In addition to describing genuairs design, which incorporates multiple feedback. Aclidinium bromide is a muscarinic antagonist and is available commercially as bretaris genuair eu members states, tudorza pressair us and canada and eklira genuair uk. The genuair inhaler is a white device fitted with an integral dose indicator and an orange dosage button. Lung hyperinflation is thought to represent a mechanical link between the characteristic expiratory airflow.
Aclidinium provides improvements in lung function, dyspnoea and diseasespecific health status in patients with copd, and is. About almirall almirall is an international pharmaceutical company based on innovation and committed to health. Brimica genuair 34012 is a dry powder inhaler that uses your breath to deliver the medicine directly into your lungs. Eklira genuair is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease copd. The active ingredient of eklira genuair is aclidinium bromide, which belongs to a group of medicines called bronchodilators. What duaklir genuair looks like and contents of the pack. Duaklir genuair is a white or almost white inhalation powder.
The primary safety endpoint was the time to first occurrence of mace, defined as any of the following. The dual objectives of this proof of concept study were to evaluate trough effects of tiotropium tio or aclidinium acl when used as triple therapy and to assess if impulse oscillometry ios might be more sensitive than. Copd patients suffer from shortness of breath, fatigue, excessive phlegm production, and frequent infections that may require hospitalization. You must hear a click as you breathe in so you know that you got the medication. Preference, satisfaction and critical errors with genuair. Eklira genuair is mentioned in 3 posts about shortness of breath. Aclidinium aclidinium bromide this medicine is subject to additional monitoring. Exercise limitation, driven predominantly by activityrelated dyspnea, is an important feature of chronic obstructive pulmonary disease copd that compromises daily living activities, leads to physical deconditioning, and contributes to a reduced perceived quality of life 16. The mouthpiece is covered with a removable orange protective cap.
Virkning og anvendelse virkning det aktive indholdsstof i eklira genuair er aclidiniumbromid, som tilhorer en r. Aclidinium bromide bretaris genuair, eklira genuair aclidiniumformoterol brimica genuair, duaklir genuair this article includes a list of related items. The inhaler design includes visual and acoustic feedback to reassure patients that they have taken their medication correctly, a dose indicator and a lockout mechanism to prevent the use of an empty inhaler. Aclidinium bromide eklira genuair is an inhaled lama administered using a breathactuated, multidose, dry powder inhaler the genuair inhaler. Each delivered dose the dose leaving the mouthpiece of eklira genuair contains 375 g. In the eu, it is indicated as maintenance bronchodilator treatment in patients with chronic obstructive pulmonary disease copd. Eklira genuair is a medicine that is used to relieve the symptoms of chronic obstructive pulmonary disease copd in adults. Chronic obstructive pulmonary disease copd affects around 64 million people worldwide and is the fourth leading cause of death.
The purpose of this leaflet is to give information on the medicines that are inside inhalers, the various types of. Eklira genuair 322 micrograms inhalation powder patient. Eklira genuair is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease copd see section 5. Pharmacovigilance risk assessment committee prac ema1586312014 page 272 gain more knowledge about the safety of the medicine and risk factors for developing side effects. Genuair almirall sa, spain is a novel, breathactuated, multidose drypowder inhaler designed to achieve reliable and effective delivery of inhaled medicines including aclidinium bromide to patients with chronic obstructive pulmonary disease. Not standing or sitting up to take the genuair inhaler. Patient information leaflet patient information leaflet last updated on medicines. Us20180105517a1 process for the preparation of aclidinium. Searching for the synergistic effect between aclidinium and formoterol. In this randomized, doubleblind, crossover study, patients with stable copd and moderatetosevere airflow limitation received aclidinium 400. Chronic obstructive pulmonary disease copd is a chronic and progressive disease.
Eklira genuair er en torpulverinhalator, som bruger dit andedr. Preference, satisfaction and critical errors with genuair and. Listing a study does not mean it has been evaluated by the u. New therapeutic indication aclidinium bromide received a european marketing authorisation in july 2012 and was launched in the uk in september 2012. Wo2016156836a1 process for the preparation of aclidinium. Watch video demonstration on how to use your inhaler. Common mistakes that people make with genuair inhalers include. Aclidinium improves exercise endurance, dyspnea, lung. Aclidinium bromide eklira genuair is an inhaled longacting muscarinic antagonist lama for maintenance bronchodilator treatment to relieve symptoms in adults with chronic obstructive pulmonary disease copd. Preference, satisfaction and ease of use of genuair. In vitro assessments of the fine particle dose genuair looks like and contents of the pack.
Put lips around mouthpiece firmly and inhale one long, steady, deep breath into your lungs. Inhalers are often used to treat chronic obstructive pulmonary disease copd. The efficacy and safety of twicedaily aclidinium bromideformoterol fumarate was compared with that of salmeterolfluticasone propionate in patients with stable, moderatetosevere chronic obstructive pulmonary disease copd. Consumer information tudorza genuair aclidinium bromide dry powder for oral inhalation this leaflet is part iii of a threepart product monograph published when tudorza genuair was approved for sale in canada and is designed specifically for consumers. A process for preparing 3r32hydroxydi2thienylacetoxyphenoxypropyl1azoniabicyclo2. After 23 weeks on the study inhaler, participants returned to the department for visit 2. This corresponds to a metered dose of 400 g aclidinium bromide equivalent to 343 g aclidinium. Aclidinium bromide eklira genuair is an inhaled longacting. Charm guidelines for the diagnosis and management of copd.
This will allow quick identification of new safety information. Tudorza pressair us is a longacting antimuscarinic agent. It is marketed under the brand name tudorza pressair in the us, eklira genuair in the uk, and tudorza genuair in canada. Almirall licenses aclidinium to invida in australia and new. Aclidinium provides improvements in lung function, dyspnoea and diseasespecific health status in patients with copd. Affirm copd aclidinium and formoterol findings in respiratory medicine copd was a 24week, doubleblind, doubledummy, activecontrolled study. Highlights of prescribing information do not use in. This compound as well as a process for its manufacture is described in wo 0104118. Eklira genuair is a common treatment for breathing and lung problems. This study evaluated the effects of aclidinium bromide, a longacting muscarinic antagonist indicated for maintenance treatment of chronic obstructive pulmonary disease copd, on exercise endurance, dyspnea, lung hyperinflation, and physical activity. See the end of section 4 for how to report side effects. Following the runin period, at visit 1, baseline measurements were recorded.
It received a european marketing authorisation in july 2012 and was launched in the uk in september 2012. Aclidinium bromide bretaris genuair, eklira genuair. The median time onstudy in the eklira genuair and placebo groups was approximately 1. Genuair is the inhaler, and part of the brand name, for the following medications. Each delivered dose the dose leaving the mouthpiece contains 375 g aclidinium bromide equivalent to 322 g of aclidinium. This substance uses the active ingredient aclidinium bromide to open your airways and reduce the risk of coughing, trouble breathing, and other symptoms associated with copd. The dual objectives of this proof of concept study were to evaluate trough effects of tiotropium tio or aclidinium acl when used as triple therapy and to assess if impulse oscillometry ios might be more sensitive. Brimica genuair inhaler aclidinium bromide formoterol. Eklira genuair is indicated as a maintenance bronchodilator treatment. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Not holding the genuair inhaler upright when using it. Eklira genuair 322 micrograms inhalation powder medicines. From bench to bedside article pdf available in respiratory medicine 10910 august 2015 with 111 reads. On this page about bretaris genuair you will find information relating to side effects, age restrictions, food interactions, whether the medicine is available at a government subsidised price on the pharmaceutical benefits scheme pbs as well as other useful information.
Jan, 2016 longacting muscarinic antagonists confer improvements in spirometry when used in addition to inhaled corticosteroids and longacting betaagonists icslaba in copd. Health canada approval of duaklir genuair offers canadians with copd a safe and reliable twiceaday option 1. The median time ontreatment in the eklira genuair and placebo groups was 1. Product overview chronic obstructive pulmonary disease. Oct 10, 2012 eklira genuair and bretaris genuair are trademarks owned by almirall, s. Apr 30, 2015 eklira genuair aclidinium bromide 2012. Eklira genuair 322 micrograms inhalation powder summary. The recommended dose is one inhalation of 322 micrograms aclidinium twice daily. Eklira genuair is used for maintenance regular treatment. Primary care respiratory update primary care respiratory society. Effects of adding tiotropium or aclidinium as triple therapy. Full text clinical potential of aclidinium bromide in. An inhaler is a device holding a medicine that you take by breathing in inhaling. Eklira genuair 322 micrograms inhalation powder aclidinium aclidinium bromide this medicine is subject to additional monitoring.
About almirall almirall is an international pharmaceutical company based on. This makes it easier for chronic obstructive pulmonary disease copd. This website is intended for uk patients prescribed a product delivered through a genuair inhaler. Duaklir genuair 340 micrograms 12 micrograms inhalation. Eklira genuair 322 micrograms inhalation powder patient information leaflet pil emc pdf source. The salt, aclidinium bromide, is a crystalline powder that is hardly soluble in water or ethanol. Efficacy and safety of aclidiniumformoterol versus. Download fulltext pdf clinical potential of aclidinium bromide in chronic obstructive pulmonary disease article pdf available in international journal of copd 10. Eklira genuair is indicated as a maintenance bronchodilator treatment to relieve symptoms inadult patients with chronic obstructive pulmonary disease copdsee section 5. Longacting muscarinic antagonists confer improvements in spirometry when used in addition to inhaled corticosteroids and longacting betaagonists icslaba in copd. Eklira genuair 322 micrograms inhalation powder summary of. Aug 04, 2017 an inhaler is a device holding a medicine that you take by breathing in inhaling.
If the control window does not turn green, you have not pressed the button firmly enough and you should try again. Inhalers are commonly prescribed for patients with asthma and chronic obstructive pulmonary disease copd as they are very effective at delivering the medication straight to the lungs where it is. Almirall licenses aclidinium to invida in australia and. Aclidinium bromide, a selective longacting, smallmolecule muscarinic m3 receptor antagonist lama, is being developed by astrazeneca for the maintenance. The video below shows stepbystep instructions on how to use your eklira genuair inhaler. Pdf searching for the synergistic effect between aclidinium.
Effects of adding tiotropium or aclidinium as triple. Eklira genuair, innaclidinium bromide european medicines agency. Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease paul w jones institute for infection and immunity, faculty of respiratory medicine, st georges, university of london, london, uk abstract. Copd is a longterm disease in which the airways and air sacs inside the lungs become damaged or blocked, leading to difficulty breathing.
68 483 843 1455 1208 774 238 178 558 17 1153 717 40 411 118 402 741 479 166 771 363 719 572 1025 205 1353 861 1384 613 1351 22 775 432 962 1052 1212 172 195 1346 314 349 740 1420 91 287 1262 317 1217 251 1064 933